--- title: "Insulin therapy: Profil presented at EASD 2017" description: Short overview of EASD 2017 presentations about insulin therapy and hypoglycemia treatment presented by Profil. image: https://blog.profil.com/hubfs/Leona_presentation.jpg --- [![profil-logo-wortbild-with claim-4c-offset_1000px](https://blog.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px.png?width=250&name=profil-logo-wortbild-with%20claim-4c-offset_1000px.png "profil-logo-wortbild-with claim-4c-offset_1000px")](https://www.profil.com) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) ![Header_1077x260px_About_Profil.jpg](https://blog.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x260px_About_Profil.jpg?width=1077&name=Header_1077x260px_About_Profil.jpg "Header_1077x260px_About_Profil.jpg") # Insulin therapy: Profil presented at EASD 2017 ![Tatiana](https://blog.profil.com/hubfs/Mitarbeiter/tatiana_hexagon.png) Posted by [Tatiana Dicenzo](https://blog.profil.com/blog/author/tatiana-dicenzo) on Oct 20, 2017 3:16:26 PM ![Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.](https://cdn2.hubspot.net/hub/3825816/hubfs/BM/IN.png?width=20&name=IN.png "Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.") ![Two clicks for more privacy: The Twitter Share button will be enabled once you click here. Activating the button already sends data to Twitter.](https://blog.profil.com/hubfs/BLUE_MOON/twitter.png "Two clicks for more privacy: The Twitter Share button will be enabled once you click here. Activating the button already sends data to Twitter.") The 53rd EASD Annual Meeting, held last month, was a great success with more than 15.000 attendants and 1266 abstracts selected. In our [last blog post](https://blog.profil.com/blog/novelties-treatment-type-2-diabetes-easd-2017), we provided you with a short overview of some of the interesting novelties presented during the meeting and, today, we are happy to share with you our own contribution to the conference: ![Leona_presentation.jpg](https://blog.profil.com/hs-fs/hubfs/Leona_presentation.jpg?width=520&height=272&name=Leona_presentation.jpg)   Dr. Leona Plum-Mörschel, our Chief Executive Officer from Profil Mainz, gave an oral presentation about the [“Efficacy and safety of oral basal insulin: eight-week feasibility study in people with type 2 diabetes”](https://www.easd.org/virtualmeeting/home.html#!resources/efficacy-and-safety-of-oral-basal-insulin-eight-week-feasibility-study-in-people-with-type-2-diabetes-cf4ce544-aad5-4fdb-a8b5-787c007e3598) during the session about insulin therapy in type 2 diabetes: novel concepts. Our Director Project Development/Medical Technology, Dr. Eric Zijlstra, delivered an oral presentation about the [“Effect of food intake on the absorption of oral basal insulin”](https://www.easd.org/virtualmeeting/home.html#!resources/effect-of-food-intake-on-the-absorption-of-oral-basal-insulin-071a102d-22fc-4156-906e-0b5292fba906) during the improvement in insulin therapy session. In the same session, our Chief Executive Officer, Dr. Christoph Kapitza gave an oral presentation on [“A novel formulation of insulin lispro shows significantly faster absorption and improvement in postprandial glucose excursions versus insulin lispro in patients with type 2 diabetes”](https://www.easd.org/virtualmeeting/home.html#!resources/a-novel-formulation-of-insulin-lispro-shows-significantly-faster-absorption-and-improvement-in-postprandial-glucose-excursions-versus-insulin-lispro-in-patients-with-type-2-diabetes-f1e65d0b-f071-4853-96af-9ed8a019b022). If you are also interested in the session about Hypoglycemia: treatment and consequences, you can check our ePoster [“Dasiglucagon, a novel soluble glucagon analogue, successfully restores blood glucose levels after hypoglycaemia in people with type 1 diabetes”](https://www.easd.org/virtualmeeting/home.html#!resources/dasiglucagon-a-novel-soluble-glucagon-analogue-successfully-restores-blood-glucose-levels-after-hypoglycaemia-in-people-with-type-1-diabetes-3092aaea-b67e-4490-8245-3fdc545dda81) presented by Dr. Tim Heise, our Lead Scientist. We hope you enjoy our presentations! If you are interested to know more about our expertise you can always arrange a meeting in one of the [upcoming conferences](https://www.profil.com/organisation/conferences) or contact [our scientists](https://www.profil.com/organization/scientists).   Topics: [The Science behind Diabetes](https://blog.profil.com/blog/topic/the-science-behind-diabetes), [Events](https://blog.profil.com/blog/topic/events) [Leave a comment](https://blog.profil.com/blog/insulin-therapy-novelties-improvements-in-therapy-presented-easd-2017#comment_form) ### Subscribe to Email Updates ### Our most popular Posts ### Posts by Topic - [Clinical Trials in Diabetes (127)](https://blog.profil.com/blog/topic/clinical-trials-in-diabetes) - [About Profil (69)](https://blog.profil.com/blog/topic/about-profil) - [Clinical Trial Methods (68)](https://blog.profil.com/blog/topic/clinical-trial-methods) - [The Science behind Diabetes (64)](https://blog.profil.com/blog/topic/the-science-behind-diabetes) - [Treating Diabetes (62)](https://blog.profil.com/blog/topic/treating-diabetes) - [Diabetes Technology (41)](https://blog.profil.com/blog/topic/diabetes-technology) - [Clinical trials in Obesity (11)](https://blog.profil.com/blog/topic/clinical-trials-in-obesity) - [Events (4)](https://blog.profil.com/blog/topic/events) - [CRO selection (2)](https://blog.profil.com/blog/topic/cro-selection) - [Regulatory Affairs (2)](https://blog.profil.com/blog/topic/regulatory-affairs) [see all](https://blog.profil.com/blog/insulin-therapy-novelties-improvements-in-therapy-presented-easd-2017#) ## You might also like this post ### ["What are glucose clamps and why do we need them?"](https://blog.profil.com/blog/what-are-glucose-clamps-and-why-do-we-need-them)